Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide

Keyphrases

• Intravenous Cyclophosphamide 100%
• Systemic Sclerosis-associated Interstitial Lung Disease 100%
• Lung Function 62%
• Respiratory Symptoms 50%
• Forced Vital Capacity 37%
• Respiratory Outcomes 25%
• University of Nottingham 12%
• Long-term Survival 12%
• Derby 12%
• Royal 12%
• University Hospital 12%
• King 12%
• Pulmonary Function Test 12%
• Treatment Cycle 12%
• Retrospective Case 12%
• Transfer Factor 12%
• Cyclophosphamide Treatment 12%
• Cyclophosphamide 12%
• 5-year Survival 12%
• Capacity Factor 12%
• Kaplan-Meier Curve 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Interstitial Lung Disease 100%
• Cyclophosphamide 100%
• Systemic Sclerosis 100%
• Symptom 50%
• Long Term Survival 12%
• Side Effect 12%
• Transfer Factor 12%

Immunology and Microbiology

• Cyclophosphamide 100%
• Systemic Scleroderma 100%
• Forced Vital Capacity 37%
• Lung Function 12%
• Long Term Survival 12%
• Transfer Factor 12%